Share Price and Basic Stock Data
Last Updated: January 2, 2026, 8:18 pm
| PEG Ratio | -10.24 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Relaxo Footwears Ltd operates in the footwear industry, reported a market capitalization of ₹10,028 Cr and a share price of ₹403. The company’s revenue from operations over the last fiscal year stood at ₹2,783 Cr, reflecting a growth trajectory from ₹2,653 Cr in the previous fiscal year. Quarterly sales have shown fluctuations, with the highest quarterly sales recorded at ₹765 Cr in March 2023, while the latest quarter (September 2023) recorded sales of ₹715 Cr. The company’s sales growth trend indicates resilience, though it can be noted that the latest quarter’s sales declined from the previous quarter’s ₹739 Cr. The trailing twelve months (TTM) revenue is reported at ₹2,645 Cr, indicating a slight contraction compared to the annual revenue for FY 2025, which is projected at ₹2,790 Cr. This performance positions Relaxo favorably, despite the challenges faced in a competitive market.
Profitability and Efficiency Metrics
Relaxo Footwears Ltd reported a net profit of ₹174 Cr, with a net profit margin of 6.10% for the fiscal year ending March 2025. The operating profit margin (OPM) stood at 14.66%, reflecting a stable profitability framework. The company recorded an operating profit of ₹385 Cr for FY 2025, showing a decline from ₹409 Cr in FY 2024. Additionally, the interest coverage ratio (ICR) was strong at 19.79x, indicating robust earnings relative to interest obligations. However, the return on equity (ROE) was reported at 8.31%, which is on the lower end compared to industry averages, suggesting room for improvement in generating returns for shareholders. The return on capital employed (ROCE) of 11.2% also indicates that while Relaxo is profitable, it may not be maximizing its capital efficiency as effectively as competitors.
Balance Sheet Strength and Financial Ratios
Relaxo Footwears Ltd’s balance sheet reflects a conservative financial strategy with total borrowings of ₹215 Cr against reserves of ₹2,085 Cr, offering a low debt-to-equity ratio of 0.00, which signals a strong equity position. The company’s current ratio stood at 2.74, demonstrating a solid liquidity position, while the quick ratio of 1.50 indicates sufficient short-term assets to cover liabilities. The book value per share was reported at ₹84.29, with a price-to-book value (P/BV) ratio of 4.83x, which is relatively high, suggesting that the stock may be overvalued compared to its net assets. The cash conversion cycle (CCC) was at 155 days, which indicates efficiency in managing inventory and receivables, although it is higher than typical sector ranges, suggesting potential areas for operational improvement.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Relaxo Footwears Ltd shows a strong promoter holding of 71.27%, which reflects significant insider confidence in the business. Institutional investors hold 12.92% of the equity, with foreign institutional investors (FIIs) at 3.04% and domestic institutional investors (DIIs) at 9.88%. This level of institutional ownership suggests a degree of credibility among professional investors. The number of shareholders has decreased to 239,270, down from 361,927 in December 2022, which may raise concerns about retail investor interest. The company’s dividend payout ratio has increased to 43.84%, indicating a commitment to returning value to shareholders, though this could also imply a reduced reinvestment in growth opportunities.
Outlook, Risks, and Final Insight
Looking ahead, Relaxo Footwears Ltd faces a mixed outlook. The company’s strong brand presence and solid financial metrics provide a foundation for potential growth; however, challenges such as fluctuating sales and a low ROE present risks. The footwear industry is competitive, with rising material costs and changing consumer preferences posing additional threats. If Relaxo can enhance its operational efficiencies and innovate product lines, it could capitalize on growth opportunities in the expanding Indian market. Conversely, failure to adapt to market trends or manage costs effectively could hinder its profitability. The company’s significant reserves offer a buffer for investments or navigating downturns, but the high P/BV ratio might deter value-focused investors. Overall, Relaxo stands at a crossroads, with its financial health supporting growth, yet operational challenges necessitating strategic attention.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Campus Activewear Ltd | 8,000 Cr. | 262 | 318/210 | 64.6 | 26.0 | 0.38 % | 20.1 % | 17.2 % | 5.00 |
| AKI India Ltd | 69.8 Cr. | 6.79 | 16.2/6.00 | 35.2 | 8.35 | 0.00 % | 4.54 % | 1.80 % | 2.00 |
| Relaxo Footwears Ltd | 10,046 Cr. | 403 | 640/375 | 57.6 | 84.7 | 0.74 % | 11.2 % | 8.31 % | 1.00 |
| Liberty Shoes Ltd | 483 Cr. | 282 | 517/260 | 36.2 | 134 | 0.00 % | 9.99 % | 7.20 % | 10.0 |
| Khadim India Ltd | 340 Cr. | 185 | 330/153 | 23.7 | 90.2 | 0.00 % | 9.34 % | 2.20 % | 10.0 |
| Industry Average | 6,213.60 Cr | 348.13 | 47.15 | 77.04 | 0.52% | 11.71% | 8.72% | 5.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 670 | 681 | 765 | 739 | 715 | 713 | 747 | 748 | 679 | 667 | 695 | 654 | 629 |
| Expenses | 610 | 609 | 647 | 631 | 624 | 626 | 627 | 649 | 592 | 584 | 583 | 555 | 547 |
| Operating Profit | 59 | 72 | 118 | 108 | 92 | 87 | 120 | 99 | 88 | 83 | 112 | 99 | 81 |
| OPM % | 9% | 11% | 15% | 15% | 13% | 12% | 16% | 13% | 13% | 12% | 16% | 15% | 13% |
| Other Income | 6 | 4 | 4 | 7 | 11 | 6 | 5 | 5 | 7 | 7 | 8 | 11 | 12 |
| Interest | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Depreciation | 31 | 32 | 33 | 35 | 37 | 38 | 38 | 39 | 40 | 40 | 39 | 40 | 39 |
| Profit before tax | 30 | 41 | 85 | 76 | 60 | 51 | 82 | 60 | 50 | 45 | 75 | 66 | 49 |
| Tax % | 26% | 26% | 26% | 26% | 27% | 24% | 25% | 26% | 26% | 26% | 25% | 26% | 26% |
| Net Profit | 22 | 30 | 63 | 56 | 44 | 39 | 61 | 44 | 37 | 33 | 56 | 49 | 36 |
| EPS in Rs | 0.90 | 1.21 | 2.54 | 2.26 | 1.78 | 1.55 | 2.47 | 1.78 | 1.48 | 1.33 | 2.26 | 1.96 | 1.45 |
Last Updated: December 29, 2025, 9:16 am
Below is a detailed analysis of the quarterly data for Relaxo Footwears Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 629.00 Cr.. The value appears to be declining and may need further review. It has decreased from 654.00 Cr. (Jun 2025) to 629.00 Cr., marking a decrease of 25.00 Cr..
- For Expenses, as of Sep 2025, the value is 547.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 555.00 Cr. (Jun 2025) to 547.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 99.00 Cr. (Jun 2025) to 81.00 Cr., marking a decrease of 18.00 Cr..
- For OPM %, as of Sep 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Jun 2025) to 13.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Jun 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 39.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.00 Cr. (Jun 2025) to 39.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 49.00 Cr.. The value appears to be declining and may need further review. It has decreased from 66.00 Cr. (Jun 2025) to 49.00 Cr., marking a decrease of 17.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Jun 2025) to 36.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.45. The value appears to be declining and may need further review. It has decreased from 1.96 (Jun 2025) to 1.45, marking a decrease of 0.51.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,180 | 1,441 | 1,668 | 1,631 | 1,941 | 2,292 | 2,410 | 2,359 | 2,653 | 2,783 | 2,914 | 2,790 | 2,645 |
| Expenses | 1,032 | 1,240 | 1,427 | 1,400 | 1,639 | 1,964 | 1,998 | 1,861 | 2,235 | 2,442 | 2,505 | 2,405 | 2,269 |
| Operating Profit | 148 | 201 | 241 | 231 | 302 | 328 | 413 | 498 | 418 | 341 | 409 | 385 | 376 |
| OPM % | 13% | 14% | 14% | 14% | 16% | 14% | 17% | 21% | 16% | 12% | 14% | 14% | 14% |
| Other Income | 2 | 0 | 7 | 14 | 4 | 12 | 8 | 22 | 23 | 16 | 29 | 27 | 38 |
| Interest | 23 | 18 | 23 | 15 | 9 | 9 | 19 | 19 | 17 | 22 | 21 | 24 | 21 |
| Depreciation | 31 | 40 | 47 | 51 | 54 | 62 | 109 | 110 | 114 | 125 | 147 | 158 | 159 |
| Profit before tax | 96 | 143 | 178 | 178 | 244 | 268 | 292 | 391 | 311 | 210 | 269 | 230 | 235 |
| Tax % | 31% | 28% | 32% | 33% | 34% | 35% | 22% | 25% | 25% | 26% | 26% | 26% | |
| Net Profit | 66 | 103 | 120 | 120 | 161 | 175 | 226 | 292 | 233 | 154 | 200 | 170 | 174 |
| EPS in Rs | 2.74 | 4.29 | 5.01 | 4.99 | 6.69 | 7.07 | 9.11 | 11.74 | 9.35 | 6.21 | 8.05 | 6.84 | 7.00 |
| Dividend Payout % | 5% | 6% | 6% | 10% | 11% | 13% | 14% | 21% | 27% | 40% | 37% | 44% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 56.06% | 16.50% | 0.00% | 34.17% | 8.70% | 29.14% | 29.20% | -20.21% | -33.91% | 29.87% | -15.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -39.56% | -16.50% | 34.17% | -25.47% | 20.45% | 0.06% | -49.41% | -13.70% | 63.78% | -44.87% |
Relaxo Footwears Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -6% |
| 3 Years: | -10% |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -5% |
| 3 Years: | -21% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 9% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:05 pm
Balance Sheet
Last Updated: December 4, 2025, 1:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 12 | 12 | 12 | 12 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 271 | 362 | 468 | 594 | 749 | 1,093 | 1,248 | 1,548 | 1,735 | 1,830 | 1,976 | 2,073 | 2,085 |
| Borrowings | 198 | 239 | 236 | 178 | 153 | 112 | 139 | 144 | 174 | 164 | 205 | 213 | 215 |
| Other Liabilities | 182 | 234 | 281 | 286 | 335 | 394 | 430 | 459 | 448 | 476 | 508 | 452 | 545 |
| Total Liabilities | 657 | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 | 2,870 |
| Fixed Assets | 366 | 472 | 531 | 541 | 525 | 848 | 981 | 938 | 987 | 1,150 | 1,371 | 1,344 | 1,336 |
| CWIP | 24 | 2 | 28 | 62 | 138 | 11 | 46 | 118 | 149 | 89 | 33 | 54 | 75 |
| Investments | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 338 | 194 | 225 | 108 | 343 | 422 |
| Other Assets | 267 | 367 | 438 | 466 | 587 | 752 | 814 | 782 | 1,052 | 1,030 | 1,202 | 1,021 | 1,037 |
| Total Assets | 657 | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 | 2,870 |
Below is a detailed analysis of the balance sheet data for Relaxo Footwears Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,073.00 Cr. (Mar 2025) to 2,085.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 215.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 213.00 Cr. (Mar 2025) to 215.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 545.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 452.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 93.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,870.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,762.00 Cr. (Mar 2025) to 2,870.00 Cr., marking an increase of 108.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,344.00 Cr. (Mar 2025) to 1,336.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 21.00 Cr..
- For Investments, as of Sep 2025, the value is 422.00 Cr.. The value appears strong and on an upward trend. It has increased from 343.00 Cr. (Mar 2025) to 422.00 Cr., marking an increase of 79.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,037.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,021.00 Cr. (Mar 2025) to 1,037.00 Cr., marking an increase of 16.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,870.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,762.00 Cr. (Mar 2025) to 2,870.00 Cr., marking an increase of 108.00 Cr..
Notably, the Reserves (2,085.00 Cr.) exceed the Borrowings (215.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -50.00 | -38.00 | 5.00 | 53.00 | 149.00 | 216.00 | 274.00 | 354.00 | 244.00 | 177.00 | 204.00 | 172.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 21 | 24 | 28 | 33 | 35 | 26 | 28 | 34 | 35 | 45 | 41 |
| Inventory Days | 109 | 163 | 147 | 146 | 130 | 130 | 157 | 154 | 202 | 154 | 179 | 177 |
| Days Payable | 39 | 61 | 63 | 63 | 72 | 58 | 65 | 81 | 67 | 69 | 76 | 63 |
| Cash Conversion Cycle | 91 | 123 | 108 | 110 | 90 | 107 | 119 | 101 | 170 | 121 | 148 | 155 |
| Working Capital Days | 5 | 14 | 12 | 19 | 27 | 42 | 57 | 44 | 75 | 59 | 68 | 62 |
| ROCE % | 26% | 30% | 30% | 26% | 30% | 26% | 24% | 26% | 18% | 12% | 14% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 11,800,000 | 1.33 | 482.92 | 1,800,000 | 2025-12-08 01:55:51 | 555.56% |
| SBI Large & Midcap Fund | 4,049,449 | 0.45 | 165.72 | 1,550,000 | 2025-12-08 01:55:51 | 161.25% |
| SBI Equity Hybrid Fund | 2,533,988 | 0.13 | 103.7 | 2,533,988 | 2025-04-22 15:16:47 | 0% |
| SBI Magnum Childrens Benefit Fund - Investment Plan | 1,812,156 | 1.47 | 74.16 | 400,000 | 2025-12-08 01:55:51 | 353.04% |
| SBI Multicap Fund | 1,621,704 | 0.28 | 66.37 | 1,621,704 | 2025-04-22 15:56:54 | 0% |
| SBI Flexicap Fund | 1,347,099 | 0.23 | 55.13 | N/A | N/A | N/A |
| ICICI Prudential Bharat Consumption Fund | 307,585 | 0.39 | 12.59 | N/A | N/A | N/A |
| SBI Consumption Opportunities Fund | 290,000 | 0.37 | 11.87 | N/A | N/A | N/A |
| ICICI Prudential FMCG Fund | 221,692 | 0.46 | 9.07 | N/A | N/A | N/A |
| UTI Multi Asset Allocation Fund | 60,298 | 0.04 | 2.47 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 6.84 | 8.05 | 6.21 | 9.36 | 11.74 |
| Diluted EPS (Rs.) | 6.84 | 8.05 | 6.21 | 9.35 | 11.74 |
| Cash EPS (Rs.) | 13.21 | 13.98 | 11.23 | 13.91 | 16.17 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 84.29 | 80.40 | 74.53 | 70.72 | 63.30 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 84.29 | 80.40 | 74.53 | 70.72 | 63.30 |
| Dividend / Share (Rs.) | 3.00 | 3.00 | 2.50 | 2.50 | 2.50 |
| Revenue From Operations / Share (Rs.) | 112.08 | 117.08 | 111.80 | 106.60 | 94.97 |
| PBDIT / Share (Rs.) | 16.43 | 17.49 | 14.24 | 17.66 | 20.86 |
| PBIT / Share (Rs.) | 10.07 | 11.57 | 9.21 | 13.09 | 16.43 |
| PBT / Share (Rs.) | 9.24 | 10.82 | 8.44 | 12.48 | 15.75 |
| Net Profit / Share (Rs.) | 6.84 | 8.05 | 6.21 | 9.35 | 11.74 |
| PBDIT Margin (%) | 14.66 | 14.94 | 12.73 | 16.56 | 21.96 |
| PBIT Margin (%) | 8.98 | 9.88 | 8.23 | 12.28 | 17.30 |
| PBT Margin (%) | 8.24 | 9.24 | 7.54 | 11.70 | 16.58 |
| Net Profit Margin (%) | 6.10 | 6.87 | 5.55 | 8.76 | 12.35 |
| Return on Networth / Equity (%) | 8.11 | 10.01 | 8.32 | 13.21 | 18.54 |
| Return on Capital Employeed (%) | 10.83 | 13.12 | 11.32 | 16.96 | 23.64 |
| Return On Assets (%) | 6.16 | 7.38 | 6.19 | 9.76 | 13.40 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 1.02 | 1.12 | 1.14 | 1.16 | 1.17 |
| Current Ratio (X) | 2.74 | 2.40 | 2.54 | 2.57 | 2.40 |
| Quick Ratio (X) | 1.50 | 1.25 | 1.34 | 1.11 | 1.46 |
| Inventory Turnover Ratio (X) | 4.82 | 1.99 | 1.91 | 2.39 | 1.99 |
| Dividend Payout Ratio (NP) (%) | 43.84 | 31.04 | 40.28 | 26.69 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 22.71 | 17.88 | 22.25 | 17.93 | 0.00 |
| Earning Retention Ratio (%) | 56.16 | 68.96 | 59.72 | 73.31 | 0.00 |
| Cash Earning Retention Ratio (%) | 77.29 | 82.12 | 77.75 | 82.07 | 0.00 |
| Interest Coverage Ratio (X) | 19.79 | 23.30 | 18.42 | 28.67 | 30.34 |
| Interest Coverage Ratio (Post Tax) (X) | 9.24 | 11.73 | 9.03 | 16.18 | 18.07 |
| Enterprise Value (Cr.) | 10084.44 | 20231.08 | 21055.11 | 26520.33 | 21706.20 |
| EV / Net Operating Revenue (X) | 3.61 | 6.94 | 7.57 | 10.00 | 9.20 |
| EV / EBITDA (X) | 24.66 | 46.46 | 59.42 | 60.35 | 41.88 |
| MarketCap / Net Operating Revenue (X) | 3.63 | 6.97 | 7.59 | 9.99 | 9.20 |
| Retention Ratios (%) | 56.15 | 68.95 | 59.71 | 73.30 | 0.00 |
| Price / BV (X) | 4.83 | 10.15 | 11.39 | 15.06 | 13.81 |
| Price / Net Operating Revenue (X) | 3.63 | 6.97 | 7.59 | 9.99 | 9.20 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Relaxo Footwears Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 13.98 (Mar 24) to 13.21, marking a decrease of 0.77.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 112.08. It has decreased from 117.08 (Mar 24) to 112.08, marking a decrease of 5.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.43. This value is within the healthy range. It has decreased from 17.49 (Mar 24) to 16.43, marking a decrease of 1.06.
- For PBIT / Share (Rs.), as of Mar 25, the value is 10.07. This value is within the healthy range. It has decreased from 11.57 (Mar 24) to 10.07, marking a decrease of 1.50.
- For PBT / Share (Rs.), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.24, marking a decrease of 1.58.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For PBDIT Margin (%), as of Mar 25, the value is 14.66. This value is within the healthy range. It has decreased from 14.94 (Mar 24) to 14.66, marking a decrease of 0.28.
- For PBIT Margin (%), as of Mar 25, the value is 8.98. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 8.98, marking a decrease of 0.90.
- For PBT Margin (%), as of Mar 25, the value is 8.24. This value is below the healthy minimum of 10. It has decreased from 9.24 (Mar 24) to 8.24, marking a decrease of 1.00.
- For Net Profit Margin (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.10, marking a decrease of 0.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 10.01 (Mar 24) to 8.11, marking a decrease of 1.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 10.83, marking a decrease of 2.29.
- For Return On Assets (%), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 6.16, marking a decrease of 1.22.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has decreased from 1.12 (Mar 24) to 1.02, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 2.74, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.50, marking an increase of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.82. This value is within the healthy range. It has increased from 1.99 (Mar 24) to 4.82, marking an increase of 2.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 43.84. This value is within the healthy range. It has increased from 31.04 (Mar 24) to 43.84, marking an increase of 12.80.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 22.71. This value is within the healthy range. It has increased from 17.88 (Mar 24) to 22.71, marking an increase of 4.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 56.16. This value is within the healthy range. It has decreased from 68.96 (Mar 24) to 56.16, marking a decrease of 12.80.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 77.29. This value exceeds the healthy maximum of 70. It has decreased from 82.12 (Mar 24) to 77.29, marking a decrease of 4.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 19.79. This value is within the healthy range. It has decreased from 23.30 (Mar 24) to 19.79, marking a decrease of 3.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 9.24, marking a decrease of 2.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,084.44. It has decreased from 20,231.08 (Mar 24) to 10,084.44, marking a decrease of 10,146.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 6.94 (Mar 24) to 3.61, marking a decrease of 3.33.
- For EV / EBITDA (X), as of Mar 25, the value is 24.66. This value exceeds the healthy maximum of 15. It has decreased from 46.46 (Mar 24) to 24.66, marking a decrease of 21.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
- For Retention Ratios (%), as of Mar 25, the value is 56.15. This value is within the healthy range. It has decreased from 68.95 (Mar 24) to 56.15, marking a decrease of 12.80.
- For Price / BV (X), as of Mar 25, the value is 4.83. This value exceeds the healthy maximum of 3. It has decreased from 10.15 (Mar 24) to 4.83, marking a decrease of 5.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Relaxo Footwears Ltd:
- Net Profit Margin: 6.1%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.83% (Industry Average ROCE: 11.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.11% (Industry Average ROE: 8.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.24
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.5
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 57.6 (Industry average Stock P/E: 47.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.1%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Footwears | Aggarwal City Square, Plot No. 10, Manglam Place, Delhi Delhi 110085 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Kumar Dua | Chairman & Managing Director |
| Mr. Mukand Lal Dua | Whole Time Director |
| Mr. Nikhil Dua | Whole Time Director |
| Mr. Gaurav Dua | Whole Time Director |
| Mr. Sushil Batra | Executive Director |
| Mr. Kuldip Singh Dhingra | Independent Director |
| Mr. Rajeev Rupendra Bhadauria | Independent Director |
| Ms. Richa Arora | Independent Director |
| Mr. Yogesh Kapur | Independent Director |
| Mr. Raj Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of Relaxo Footwears Ltd?
Relaxo Footwears Ltd's intrinsic value (as of 02 January 2026) is ₹326.74 which is 18.92% lower the current market price of ₹403.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹10,046 Cr. market cap, FY2025-2026 high/low of ₹640/375, reserves of ₹2,085 Cr, and liabilities of ₹2,870 Cr.
What is the Market Cap of Relaxo Footwears Ltd?
The Market Cap of Relaxo Footwears Ltd is 10,046 Cr..
What is the current Stock Price of Relaxo Footwears Ltd as on 02 January 2026?
The current stock price of Relaxo Footwears Ltd as on 02 January 2026 is ₹403.
What is the High / Low of Relaxo Footwears Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Relaxo Footwears Ltd stocks is ₹640/375.
What is the Stock P/E of Relaxo Footwears Ltd?
The Stock P/E of Relaxo Footwears Ltd is 57.6.
What is the Book Value of Relaxo Footwears Ltd?
The Book Value of Relaxo Footwears Ltd is 84.7.
What is the Dividend Yield of Relaxo Footwears Ltd?
The Dividend Yield of Relaxo Footwears Ltd is 0.74 %.
What is the ROCE of Relaxo Footwears Ltd?
The ROCE of Relaxo Footwears Ltd is 11.2 %.
What is the ROE of Relaxo Footwears Ltd?
The ROE of Relaxo Footwears Ltd is 8.31 %.
What is the Face Value of Relaxo Footwears Ltd?
The Face Value of Relaxo Footwears Ltd is 1.00.